101 related articles for article (PubMed ID: 8526413)
1. [Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].
Germain D
Ann Dermatol Venereol; 1995; 122(4):187-204. PubMed ID: 8526413
[TBL] [Abstract][Full Text] [Related]
2. Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review.
Doolan BJ; Lavallee M; Hausser I; Pope FM; Seneviratne SL; Winship IM; Burrows NP
J Am Acad Dermatol; 2023 Sep; 89(3):551-559. PubMed ID: 36764582
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between
Lim PJ; Lindert U; Opitz L; Hausser I; Rohrbach M; Giunta C
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31288483
[TBL] [Abstract][Full Text] [Related]
4. Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene.
Höpperger S; Spathopoulou A; Mayer-Suess L; Suarez-Cubero M; Sillaber K; Spreiz A; Kiechl S; Edenhofer F; Fellner L
Stem Cell Res; 2024 Mar; 75():103321. PubMed ID: 38301384
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines.
Xu K; Li G; Wu Z; Zhang TJ; Wu N;
Orphanet J Rare Dis; 2024 May; 19(1):194. PubMed ID: 38741208
[TBL] [Abstract][Full Text] [Related]
6. Ehlers-Danlos Syndrome Type VIIC: A Mexican Case Report.
Rincón-Sánchez AR; Arce IE; Tostado-Rabago EA; Vargas A; Padilla-Gómez LA; Bolaños A; Barrios-Guyot S; Anguiano-Alvarez VM; Ledezma-Rodríguez VC; Islas-Carbajal MC; Rivas-Estilla AM; Feria-Velasco A; Dávalos NO
Case Rep Dermatol; 2012 Jan; 4(1):104-13. PubMed ID: 22787447
[TBL] [Abstract][Full Text] [Related]
7. Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome.
Vandersteen AM; Weerakkody RA; Parry DA; Kanonidou C; Toddie-Moore DJ; Vandrovcova J; Darlay R; Santoyo-Lopez J; Meynert A; ; Kazkaz H; Grahame R; Cummings C; Bartlett M; Ghali N; Brady AF; Pope FM; van Dijk FS; Cordell HJ; Aitman TJ
J Med Genet; 2024 Feb; 61(3):232-238. PubMed ID: 37813462
[TBL] [Abstract][Full Text] [Related]
8. Homozygous splice site variant affecting the first von Willebrand factor A domain of COL12A1 in a patient with myopathic Ehlers-Danlos syndrome.
Furuhata-Yoshimura M; Yamaguchi T; Izu Y; Kosho T
Am J Med Genet A; 2023 Oct; 191(10):2631-2639. PubMed ID: 37353357
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome.
Artoni A; Bassotti A; Abbattista M; Marinelli B; Lecchi A; Gianniello F; Clerici M; Bucciarelli P; La Marca S; Peyvandi F; Martinelli I
J Thromb Haemost; 2018 Dec; 16(12):2425-2431. PubMed ID: 30312027
[TBL] [Abstract][Full Text] [Related]
10. Loss of Col3a1, the gene for Ehlers-Danlos syndrome type IV, results in neocortical dyslamination.
Jeong SJ; Li S; Luo R; Strokes N; Piao X
PLoS One; 2012; 7(1):e29767. PubMed ID: 22235340
[TBL] [Abstract][Full Text] [Related]
11. Neuro-ophthalmic manifestations of Ehlers-Danlos syndrome.
Rachapudi SS; Laylani NA; Davila-Siliezar PA; Lee AG
Curr Opin Ophthalmol; 2023 Nov; 34(6):476-480. PubMed ID: 37729660
[TBL] [Abstract][Full Text] [Related]
12. Conservative management of small bowel perforation in Ehlers-Danlos syndrome type IV.
Allaparthi S; Verma H; Burns DL; Joyce AM
World J Gastrointest Endosc; 2013 Aug; 5(8):398-401. PubMed ID: 23951395
[TBL] [Abstract][Full Text] [Related]
13. Skin fragility and wound management in Ehlers- Danlos Syndrome: a report by the Ehlers Danlos Syndrome society skin working group.
Angwin C; Doolan BJ; Hausser I; Labine B; Lavallee M; Mackay D; Pope FM; Seneviratne SL; Winship I; Burrows NP
Clin Exp Dermatol; 2024 May; ():. PubMed ID: 38767179
[TBL] [Abstract][Full Text] [Related]
14. Ehlers-Danlos: A Literature Review and Case Report in a Colombian Woman with Multiple Comorbidities.
Fajardo-Jiménez MJ; Tejada-Moreno JA; Mejía-García A; Villegas-Lanau A; Zapata-Builes W; Restrepo JE; Cuartas GP; Hernandez JC
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421793
[TBL] [Abstract][Full Text] [Related]
15. Local Net Charge State of Collagen Triple Helix Is a Determinant of FKBP22 Binding to Collagen III.
Ishikawa Y; Bonna A; Gould DB; Farndale RW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894834
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes.
Schubart JR; Mills SE; Schaefer EW; Bascom R; Francomano CA
Am J Med Genet A; 2022 Apr; 188(4):1204-1213. PubMed ID: 34994522
[TBL] [Abstract][Full Text] [Related]
17. Recurrent venous thrombosis in Ehlers-Danlos syndrome type III: an atypical manifestation.
Jiménez-Encarnación E; Vilá LM
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814193
[TBL] [Abstract][Full Text] [Related]
18. Homozygous factor V Leiden mutation in type IV Ehlers-Danlos patient.
Refaat M; Hotait M; Winston B
World J Clin Cases; 2014 Mar; 2(3):75-7. PubMed ID: 24653990
[TBL] [Abstract][Full Text] [Related]
19. Barriers to the Diagnosis, Care, and Management of Pediatric Patients With Ehlers-Danlos Syndrome in the United States: A Qualitative Analysis.
Black WR; Black LL; Jones JT
Glob Pediatr Health; 2023; 10():2333794X231212081. PubMed ID: 38024462
[No Abstract] [Full Text] [Related]
20. Hereditary connective tissue diseases in young adult stroke: a comprehensive synthesis.
Vanakker OM; Hemelsoet D; De Paepe A
Stroke Res Treat; 2011 Jan; 2011():712903. PubMed ID: 21331163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
